Statistics
Publications
1
Citations
32
H-Index
1
Active since
2022
Affiliations
AbbVie (United States)(Current)
Leyu Wang is an author at AbbVie (United States) specializing in tumor-associated antigens, pharmacology, and antibody conjugates.
Publications per year
2022–2022
1
1
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate
Shweta Singh, Laura Serwer, Amy DuPage et al. · Molecular Cancer Therapeutics · 2022 · 32 citations · Full text
Medicine, Oncology, Pharmacology +17
1–1 of 1